HNN3.0
Register
Register
Register

Project cooperationUpdated on 17 December 2025

Rapid immune response novel platform, animal free

Lecturer in Glycosciences at University of Galway

Galway, Ireland

About

We have developed a NAM to profile immune response by multiplexed measuring of (serum) antibody response to antigens, and antibody effector function. Can measure IC50s and Kd (multiplexed). Can incorporate genetic variability in terms of immune receptors. This NAM can be used to advance research and regulatory testing, and categorise clinical response and for prognostics. Can be used with small molecules to model immune response. Measure and predict effector function of mAbs therapeutics, and vaccine responses.

Interested in participating in a project as a partner.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

Type

  • Partner seeks Consortium/Coordinator

Organisation

University of Galway

University

Galway, Ireland

Similar opportunities

  • Project cooperation

    Rapid immune response novel platform, diagnostics prognostics

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Michelle Kilcoyne

    Lecturer in Glycosciences at University of Galway

    Galway, Ireland

  • Project cooperation

    Development of human vascularized organ-on-chip systems as New Approach Methodologies (NAMs) for disease modeling and drug testing

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Mark Davison

    Research and Innovation Projects Coordinator - EC at Technion Israel Institute of Technology

    Haifa, Israel

  • Project cooperation

    T cell-based diagnostic test development

    Alex Olvera van der Stoep

    Research Associate at IrsiCaixa

    Badalona, Spain